Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Clinical trial NCT06954805 · RECRUITING

Trial details

NCT number: NCT06954805
Sponsor: Jennifer Amengual
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma Lymphoma, B-Cell

Start date: 2025-04-14
Primary completion: 2027-04-14
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.